1. Home
  2. VVX vs GENB Comparison

VVX vs GENB Comparison

Compare VVX & GENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo V2X Inc.

VVX

V2X Inc.

HOLD

Current Price

$70.14

Market Cap

2.2B

ML Signal

HOLD

GENB

Generate Biomedicines Inc. Common Stock

HOLD

Current Price

$12.95

Market Cap

1.9B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
VVX
GENB
Founded
2014
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Diversified Commercial Services
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
1.9B
IPO Year
2014
2026

Fundamental Metrics

Financial Performance
Metric
VVX
GENB
Price
$70.14
$12.95
Analyst Decision
Buy
Strong Buy
Analyst Count
12
6
Target Price
★ $88.91
$27.00
AVG Volume (30 Days)
375.3K
★ 1.0M
Earning Date
11-02-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 126.85
N/A
EPS
★ 1.41
N/A
Revenue
★ $4,480,038,000.00
N/A
Revenue This Year
$11.07
N/A
Revenue Next Year
$5.30
N/A
P/E Ratio
$49.93
★ N/A
Revenue Growth
★ 3.65
N/A
52 Week Low
$50.89
$11.00
52 Week High
$93.98
$22.67

Technical Indicators

Market Signals
Indicator
VVX
GENB
Relative Strength Index (RSI) 44.60 38.08
Support Level $66.71 $11.82
Resistance Level $71.69 $13.96
Average True Range (ATR) 2.42 0.83
MACD 0.11 -0.18
Stochastic Oscillator 52.35 20.19

Price Performance

Historical Comparison
VVX
GENB

About VVX V2X Inc.

V2X Inc is a U.S.-based company that provides services to the U.S. government. It operates as one segment and offers facility and logistics services and information technology mission support and engineering and digital integration services. The information technology and network communications capabilities consist of communications systems operations and maintenance, management and service support, systems installation and activation, system-of-systems engineering and software development, and mission support for the department of defense. The facility and logistics service include airfield management, ammunition management, civil engineering, communications, emergency services, life support activities, public works, security, transportation operations, and others.

About GENB Generate Biomedicines Inc. Common Stock

Generate Biomedicines Inc is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company's single operating segment is engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics. Its product candidates include: GB-0895, GB-4362, and GB-5267. Through the company's Generate Platform, it can generate medicines on demand across multiple therapeutic modalities with unprecedented speed representing a fundamental shift in drug discovery.

Share on Social Networks: